Nakamura, Toshitaka https://orcid.org/0000-0002-4248-2058
Conrad, Marcus https://orcid.org/0000-0003-1140-5612
Article History
Received: 9 February 2024
Accepted: 17 April 2024
First Online: 10 June 2024
Competing interests
: M.C. is a co-founder and shareholder of ROSCUE Therapeutics. M.C. and T.N. have filed patents for some of the compounds described herein.